Skip to main content
Erschienen in: Rheumatology International 11/2016

01.09.2016 | Genes and Disease

Prevalence and significance of MEFV gene mutations in patients with gouty arthritis

verfasst von: Ahmet Karaarslan, Senol Kobak, Işın Kaya, Nazım Intepe, Mehmet Orman, Afig Berdelı

Erschienen in: Rheumatology International | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Gouty arthritis is a chronic erosive autoinflammatory disease. Pyrin has anti-inflammatory effects in the regulation of inflammasome and is encoded by the MEFV gene. The relationship between different rheumatic diseases and the MEFV gene mutations was demonstrated. The aim of this study was to determine the frequency of MEFV gene mutations in patients with gouty arthritis and identify a possible correlation with disease phenotype. Ninety-three patients with gouty arthritis and 102 healthy controls, compatible with age, gender and ethnicity, were included in the study. MEFV gene mutations were investigated by PCR method. Out of 93 patients with gouty arthritis, 36 (38.7 %) showed MEFV gene mutations carriage, whereas 20.6 % in healthy control group. Distribution of mutations identified in patients with gouty arthritis was as; R202Q in 18 (19.3 %), E148Q in 5 (5.4 %), K695R in 4 (4.3 %), M680I in 2 (2.1 %), V726A in 2 (2.1 %), P369S in 2 (2.1 %), R408Q in 2 (2.1 %), M694 V in 1 (1.1 %), respectively. Three patients were identified with compound heterozygosity. Distribution of MEFV gene mutations carriage in healthy controls was; E148Q in 11 (10.7 %), M694 V in 2 (1.9 %), M694I in 1 (0.9 %), M680I in 2 (1.9 %), V726A in 1 (0.9 %), A744S in 1 (0.9 %), K695R in 2 (1.9 %), and P369S in 1 (0.9 %) patients, respectively. Higher MEFV gene mutations carrier frequency was observed in patients with gouty arthritis, compared with the control group (p = 0.009). Heterozygous R202Q was the most common mutation detected in patients with gouty arthritis, while heterozygous E148Q in healthy control group. Statistically significant difference was not detected between clinical findings of gouty arthritis and the MEFV gene mutations (p > 0.05). We determined higher prevalence of MEFV gene mutations in patients with gouty arthritis compared with the healthy control group. The most frequently detected mutation was heterozygous R202Q, whereas E148Q in healthy controls. High carriage rates of MEFV gene mutations in gouty arthritis suggest that it may play an important role in the pathogenesis of the disease and predisposition to the disease.
Literatur
2.
Zurück zum Zitat Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29:2403–2406PubMed Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29:2403–2406PubMed
3.
Zurück zum Zitat Perez-Ruiz F, Castillo E, Chinchilla SP, Herrero-Beites AM (2014) Clinical manifestations and diagnosis of gout. Rheum Dis Clin North Am 40(193–206):3 Perez-Ruiz F, Castillo E, Chinchilla SP, Herrero-Beites AM (2014) Clinical manifestations and diagnosis of gout. Rheum Dis Clin North Am 40(193–206):3
4.
Zurück zum Zitat Pope RM, Tschopp J (2007) The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum 56:3183–3188CrossRefPubMed Pope RM, Tschopp J (2007) The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum 56:3183–3188CrossRefPubMed
5.
Zurück zum Zitat Savic S, Dickie LJ, Battellino M, McDermott MF (2012) Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases. Curr Opin Rheumatol 24(1):103–112CrossRefPubMed Savic S, Dickie LJ, Battellino M, McDermott MF (2012) Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases. Curr Opin Rheumatol 24(1):103–112CrossRefPubMed
6.
Zurück zum Zitat Yilmaz E, Ozen S, Balci B et al (2001) Mutation frequency of Familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 9:553–555CrossRefPubMed Yilmaz E, Ozen S, Balci B et al (2001) Mutation frequency of Familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 9:553–555CrossRefPubMed
7.
Zurück zum Zitat Yigit S, Bagci H, Ozkaya O et al (2008) MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience. J Rheumatol 35:106–113PubMed Yigit S, Bagci H, Ozkaya O et al (2008) MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience. J Rheumatol 35:106–113PubMed
8.
Zurück zum Zitat Tunca M, Akar S, Hawkins PN et al (2002) The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever. Eur J Hum Genet 10:786–789CrossRefPubMed Tunca M, Akar S, Hawkins PN et al (2002) The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever. Eur J Hum Genet 10:786–789CrossRefPubMed
9.
Zurück zum Zitat Pras E, Aksentijevich I, Gruberg L et al (1992) Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 326:1509–1513CrossRefPubMed Pras E, Aksentijevich I, Gruberg L et al (1992) Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 326:1509–1513CrossRefPubMed
10.
Zurück zum Zitat Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R, Besbas N (2003) Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 30(9):2014–2018PubMed Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R, Besbas N (2003) Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 30(9):2014–2018PubMed
11.
Zurück zum Zitat Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol. 27(2 Suppl 53):S29–S31PubMed Ozen S (2009) Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol. 27(2 Suppl 53):S29–S31PubMed
12.
Zurück zum Zitat Oztürk A, Ozçakar B, Ekim M, Akar N (2008) Is MEFV gene Arg202Gln (605 G>A) a disease-causing mutation? Turk J Med Sci 38:205–208 Oztürk A, Ozçakar B, Ekim M, Akar N (2008) Is MEFV gene Arg202Gln (605 G>A) a disease-causing mutation? Turk J Med Sci 38:205–208
13.
Zurück zum Zitat Yigit S, Karakus N, Tasliyurt T, Kaya SU, Bozkurt N, Kisacik B (2012) Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients. Gene 506:43–45CrossRefPubMed Yigit S, Karakus N, Tasliyurt T, Kaya SU, Bozkurt N, Kisacik B (2012) Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients. Gene 506:43–45CrossRefPubMed
14.
Zurück zum Zitat Çankaya T, Bora E, Bayram MT, Ülgenalp A, Kavukçu S, Türkmen MA, Soylu A (2015) Clinical significance of R202Q alteration of MEFV gene in children with familial Mediterranean fever. Arch Rheumatol 30(1):51–56CrossRef Çankaya T, Bora E, Bayram MT, Ülgenalp A, Kavukçu S, Türkmen MA, Soylu A (2015) Clinical significance of R202Q alteration of MEFV gene in children with familial Mediterranean fever. Arch Rheumatol 30(1):51–56CrossRef
15.
Zurück zum Zitat Onen F, Sumer H, Turkay S et al (2004) Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin Exp Rheumatol 22:S31–S33PubMed Onen F, Sumer H, Turkay S et al (2004) Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin Exp Rheumatol 22:S31–S33PubMed
16.
Zurück zum Zitat Cobankara V, Fidan G, Türk T et al (2004) The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin Exp Rheumatol 22:S27–S30PubMed Cobankara V, Fidan G, Türk T et al (2004) The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin Exp Rheumatol 22:S27–S30PubMed
17.
Zurück zum Zitat Tunca M, Akar S, Hawkins PN et al (2002) The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever. Eur J Hum Genet 10:786–789CrossRefPubMed Tunca M, Akar S, Hawkins PN et al (2002) The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever. Eur J Hum Genet 10:786–789CrossRefPubMed
18.
Zurück zum Zitat Durmus D, Alayli G, Cengiz K et al (2009) Clinical significance of MEFV mutations in ankylosing spondylitis. Joint Bone Spine 76:260–264CrossRefPubMed Durmus D, Alayli G, Cengiz K et al (2009) Clinical significance of MEFV mutations in ankylosing spondylitis. Joint Bone Spine 76:260–264CrossRefPubMed
19.
Zurück zum Zitat Cattan D, Notarnicola C, Molinari N et al (2000) Inflammatory bowel disease in non-Ashkenazi Jews with Familial Mediterranean fever. Lancet 355:378–379CrossRefPubMed Cattan D, Notarnicola C, Molinari N et al (2000) Inflammatory bowel disease in non-Ashkenazi Jews with Familial Mediterranean fever. Lancet 355:378–379CrossRefPubMed
20.
Zurück zum Zitat Akman-Demir G, Gul A, Gurol E et al (2006) Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? J Neurol 253:928–934CrossRefPubMed Akman-Demir G, Gul A, Gurol E et al (2006) Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? J Neurol 253:928–934CrossRefPubMed
21.
Zurück zum Zitat Koca SS, Etem EO, Isik B, Yuce H, Ozgen M, Dag MS, Isik A (2010) Prevalence and significance of MEFV gene mutations in a cohort of patients with rheumatoid arthritis. Joint Bone Spine 77(1):32–35CrossRefPubMed Koca SS, Etem EO, Isik B, Yuce H, Ozgen M, Dag MS, Isik A (2010) Prevalence and significance of MEFV gene mutations in a cohort of patients with rheumatoid arthritis. Joint Bone Spine 77(1):32–35CrossRefPubMed
22.
Zurück zum Zitat Cosan F, Ustek D, Oku B, Duymaz-Tozkir J, Cakiris A, Abaci N, Ocal L, Aral O, Gül A (2010) Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum 62(11):3232–3236CrossRefPubMed Cosan F, Ustek D, Oku B, Duymaz-Tozkir J, Cakiris A, Abaci N, Ocal L, Aral O, Gül A (2010) Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum 62(11):3232–3236CrossRefPubMed
23.
Zurück zum Zitat Fidder H, Chowers Y, Ackerman Z, Pollak RD, Crusius JB, Livneh A, Bar-Meir S, Avidan B, Shinhar Y (2005) The familial Mediterranean fever (MEVF) gene as a modifier of Crohn’s disease. Am J Gastroenterol 100(2):338–343CrossRefPubMed Fidder H, Chowers Y, Ackerman Z, Pollak RD, Crusius JB, Livneh A, Bar-Meir S, Avidan B, Shinhar Y (2005) The familial Mediterranean fever (MEVF) gene as a modifier of Crohn’s disease. Am J Gastroenterol 100(2):338–343CrossRefPubMed
24.
Zurück zum Zitat Atagunduz P, Ergun T, Direskeneli H (2003) MEFV mutations are increased in Behçet’s disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol. 21(4 Suppl 30):S35–S37PubMed Atagunduz P, Ergun T, Direskeneli H (2003) MEFV mutations are increased in Behçet’s disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol. 21(4 Suppl 30):S35–S37PubMed
25.
Zurück zum Zitat Sari I, Simsek I, Tunca Y, Kisacik B, Erdem H et al (2014) Is there a relationship between gouty arthritis and Mediterranean fever gene mutations? Rev Bras Reumatol 55(4):325–329CrossRefPubMed Sari I, Simsek I, Tunca Y, Kisacik B, Erdem H et al (2014) Is there a relationship between gouty arthritis and Mediterranean fever gene mutations? Rev Bras Reumatol 55(4):325–329CrossRefPubMed
26.
27.
Zurück zum Zitat Punzi L, Scanu A, Ramonda R, Oliviero F (2012) Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets. Autoimmun Rev 12(66–71):12 Punzi L, Scanu A, Ramonda R, Oliviero F (2012) Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets. Autoimmun Rev 12(66–71):12
28.
Zurück zum Zitat Merriman TR, Choi HK, Dalbeth N (2014) The genetic basis of gout. Rheum Dis Clin North Am 40(2):279–290CrossRefPubMed Merriman TR, Choi HK, Dalbeth N (2014) The genetic basis of gout. Rheum Dis Clin North Am 40(2):279–290CrossRefPubMed
Metadaten
Titel
Prevalence and significance of MEFV gene mutations in patients with gouty arthritis
verfasst von
Ahmet Karaarslan
Senol Kobak
Işın Kaya
Nazım Intepe
Mehmet Orman
Afig Berdelı
Publikationsdatum
01.09.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 11/2016
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3560-x

Weitere Artikel der Ausgabe 11/2016

Rheumatology International 11/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.